This is still in the very early stages of research.They have started phase II of the clinical trials. Retinal Pigment Epithelial Transplant Geographic Atrophy By: Michael Johnson, MD – Eastern Maine Medical Center For years,… read more →
This is research is taking place in London, England. It has a long road ahead. Once it comes over to America it will need to go through clinical trails and be approved by the FDA.… read more →
BioTime Announces New Positive Data from OpRegen® Trial in Dry-AMD ALAMEDA, Calif.–(Business Wire)–BioTime, Inc., a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced new data from the Phase I/IIa clinical trial… read more →
Shire studies SHP640 for infectious conjunctivitis The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and corticosteroid being evaluated for treating infectious keratitis in… read more →
Vascular Safety of Ranibizumab in Patients With Diabetic Macular Edema MedicalResearch.com Interview with: Marco A Zarbin, MD, PhD, FACS Alfonse Cinotti, MD/Lions Eye Research Professor and Chair Institute of Ophthalmology & Visual Science Rutgers-New Jersey Medical… read more →
BioTime Expands OpRegen® Clinical Trial in Dry-AMD With Opening of First US Sites ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced the expansion of its… read more →
A TINY MICROPHONE Measuring blood flow at the back of the eye with a device that can fit in a contact lens could help diagnose AMD and diabetic retinopathy by Selina Powell A transparent device… read more →
AMD is all about different genes.- MDA New Research leading to clinical trials Rockville gene therapy company to begin trials for treatment for leading cause of blindness by: Tina Reed Rockville-based RegenxBio Inc. has received Food… read more →
Progression From No AMD to Intermediate AMD as Influenced by Antioxidant Treatment and Genetic Risk: An Analysis of Data From the Age-Related Eye Disease Study Cataract Trial ASRS-American Society of Retina Specialists Journal of VitreoRetinal… read more →
Drug based on antibody discovered in sharks blood to be tested in humans Evidence is also emerging of the drug’s potential to combat a type of non-alcoholic fatty liver disease and age-related macular degeneration. by:… read more →